Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rony Dahan

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|February 25, 2025
CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigensSara W Feigelson, Tali Dadosh, Nehora Levi, et al.
Science Advances|February 25, 2022
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanismChanghao He, Rachana R Maniyar, Yahel Avraham, et al.
Cell|January 19, 2024
Bispecific dendritic-T cell engager potentiates anti-tumor immunityYuval Shapir Itai, Oren Barboy, Ran Salomon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitisRoberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Cell Reports|December 9, 2021
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation patternInbal Farkash, Tali Feferman, Noy Cohen-Saban, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodiesDavid Knorr, Rom Leidner, Shawn Jensen, et al.
Nano Letters|May 26, 2022
Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 DiabetesArbel Artzy-Schnirman, Enas Abu-Shah, Rona Chandrawati, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Unified platform for genetic and serological detection of COVID-19 with single-molecule technologyNoa Furth, Shay Shilo, Niv Cohen, et al.
Plos One|July 26, 2021
Unified platform for genetic and serological detection of COVID-19 with single-molecule technologyNoa Furth, Shay Shilo, Niv Cohen, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|February 25, 2025
CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigensSara W Feigelson, Tali Dadosh, Nehora Levi, et al.
Science Advances|February 25, 2022
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanismChanghao He, Rachana R Maniyar, Yahel Avraham, et al.
Cell|January 19, 2024
Bispecific dendritic-T cell engager potentiates anti-tumor immunityYuval Shapir Itai, Oren Barboy, Ran Salomon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitisRoberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Cell Reports|December 9, 2021
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation patternInbal Farkash, Tali Feferman, Noy Cohen-Saban, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodiesDavid Knorr, Rom Leidner, Shawn Jensen, et al.
Nano Letters|May 26, 2022
Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 DiabetesArbel Artzy-Schnirman, Enas Abu-Shah, Rona Chandrawati, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Unified platform for genetic and serological detection of COVID-19 with single-molecule technologyNoa Furth, Shay Shilo, Niv Cohen, et al.
Plos One|July 26, 2021
Unified platform for genetic and serological detection of COVID-19 with single-molecule technologyNoa Furth, Shay Shilo, Niv Cohen, et al.
Pageof 4